Browse > Article

Influences of Saliva Substitutes on Salivary Enzymatic Activity  

Kho, Hong-Seop (Dept. of Oral Medicine & Oral Diagnosis, School of Dentistry & Dental Research Institute, Seoul National University)
Lee, Sung-Woo (Dept. of Oral Medicine & Oral Diagnosis, School of Dentistry & Dental Research Institute, Seoul National University)
Publication Information
Journal of Oral Medicine and Pain / v.34, no.3, 2009 , pp. 227-235 More about this Journal
Abstract
Many of the protective functions of saliva can be attributed to the biological, physical, structural, and rheological characteristics of salivary glycoproteins. Therefore, the development of ideal saliva substitutes requires understanding of the rheological as well as biological properties of human saliva. In the present study, we investigated the changes of salivary enzymatic activities by saliva substitutes and compared viscosity of saliva substitutes with human saliva. Five kinds of saliva substitutes such as Moi-Stir, Stoppers4, MouthKote, Saliva Orthana, and SNU were used. Lysozyme activity was determined by the turbidimetric method. Peroxidase activity was determined with an NbsSCN assay. $\alpha$-Amylase activity was determined using a chromogenic substrate, 2-chloro-p-nitrophenol linked with maltotriose. The pH values of saliva substitutes were measured and their viscosity values were measured with a cone-and-plate digital viscometer at six different shear rates. Various types of saliva substitutes affected the activities of salivary enzymes in different ways. Stoppers4 enhanced the enzymatic activities of hen egg-white lysozyme, bovine lactoperoxidase (bLP), and $\alpha$-amylase. Saliva Orthana and SNU inhibited bLP activity and enhanced $\alpha$-amylase activity. MouthKote inhibited $\alpha$-amylase activity. Moi-Stir inhibited the enzymatic activities of bLP and $\alpha$-amylase. The pH values were very different according to the types of saliva substitutes. Stoppers4, MouthKote, and Saliva Orthana showed lower values of viscosity at low shear rates and higher values of viscosity at high shear rates compared with unstimulated and stimulated whole saliva. Moi-Stir and SNU displayed much higher values of viscosity than those of natural whole saliva. Collectively, our results indicate that each saliva substitute has its own biological and rheological characteristics. Each saliva substitute affects the enzymatic activity of salivary enzyme and finally oral health in different ways.
Keywords
Saliva substitute; Lysozyme; Peroxidase; Amylase; Saliva;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Von Bültzingslowen I, Sollecito TP, Fox PC et al. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(Suppl 1):S57.e1-S57.e15   DOI   ScienceOn
2 Vissink A, 's-Gravenmade EJ, Panders AK et al. A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes. Int J Oral Surg 1983;12:232-238   DOI   PUBMED
3 Duxbury AJ, Thakker NS, Wastell DG. A double-blind cross-over trial of a mucin-containing artificial saliva. Br Dent J 1989;166:115-120   DOI   ScienceOn
4 Johansson G, Andersson G, Attström R, Glantz PO, Larsson K. The effect of Salinum on the symptoms of dry mouth: a pilot study. Gerodontology 1994;11: 46-49   DOI   PUBMED
5 Lee SG, Jeon EH, Kho HS. Influences of animal mucins on peroxidase activity in solution and on the surface of hydroxyapatite. Korean J Oral Med 2008;33: 229-240
6 Bennick A, Cannon M. Quantitative study of the interaction of salivary acidic proline-rich proteins with hydroxyapatite. Caries Res 1978;12:159-169   DOI   ScienceOn
7 Jolles P, Jolles J. What's new in lysozyme research? Always a model system, today as yesterday. Mol Cell Biochem 1984;63:165-189   DOI   PUBMED
8 O'Brien PJ. Peroxidases. Chem Biol Interact 2000;129:113-139   DOI   ScienceOn
9 Scannapieco FA, Torres G, Levine MJ. Salivary $\alpha$-amylase: role in dental plaque and caries formation. Crit Rev Oral Biol Med 1993;4:301-307   DOI
10 Iontcheva I, Oppenheim FG, Troxler RF. Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins. J Dent Res 1997;76:734-743   DOI   ScienceOn
11 Cohen RE, Levine MJ. Salivary glycoproteins. In: Tenovuo JO, ed. Human Saliva: Clinical Chemistry and Microbiology. Vol I. Boca Raton, 1989, CRC Press Inc., pp. 101-130
12 Regelink G, Vissink A, Reintsema H, Nauta JM. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int 1998;29:383-388   PUBMED
13 Olsson H, Axell T. Objective and subjective efficacy of saliva substitutes containing mucin and carboxymethylcellulose. Scand J Dent Res 1991;99:316-319   DOI   PUBMED
14 Fox PC. Systemic therapy of salivary gland hypofunction. J Dent Res 1987;66:689-692   DOI   PUBMED
15 Ihalin R, Loimaranta V, Tenovuo J. Origin, structure, and biological activities of peroxidases in human saliva. Arch Biochem Biophys 2006;445:261-268   DOI   ScienceOn
16 Levine MJ, Aguirre A, Hatton MN, Tabak LA. Artificial saliva: Present and future. J Dent Res 1987;66:693-698   DOI   PUBMED
17 Park MS, Chung JW, Kim YK, Chung SC, Kho HS. Viscosity and wettability of animal mucin solutions and human saliva. Oral Dis 2007;13:181-186   DOI   ScienceOn
18 Ihalin R, Loimaranta V, Tenovuo J. Origin, structure, and biological activities of peroxidases in human saliva. Arch Biochem Biophys 2006;445:261-268   DOI   ScienceOn
19 Thomson WM, Lawrence HP, Broadbent JM, Poulton R. The impact of xerostomia on oral-health-related quality of life among younger adults. Health Qual Life Outcomes 2006;4:86   DOI   ScienceOn
20 Vissink A, Schaub RMH, Van Rijn LJ, s-Gravenmade EJ, Panders AK, Vermey A. The efficacy of mucincontaining artificial saliva in alleviating symptoms of xerostomia. Gerodontology 1987;6:95-101   DOI   PUBMED
21 Laible NJ, Germaine GR. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Infect Immun 1985;48:720-728   PUBMED
22 Hatton MN, Levine MJ, Margarone JE, Aguirre A. Lubrication and viscosity features of human saliva and commercially available saliva substitutes. J Oral Maxillofac Surg 1987;45:496-499   DOI
23 Fox PC, Busch K, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 1987;115:581-584   DOI
24 Soares RV, Siqueira CC, Bruno LS, Oppenheim FG, Offner GD, Troxler RF. MG2 and lactoferrin form a heterotypic complex in salivary secretions. J Dent Res 2003;82:471-475   DOI   ScienceOn
25 Ikebe K, Matsida K, Morri K et al. Impact of dry mouth and hyposalivation on oral health-related quality of life of elderly Japanese. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:216-222   DOI   ScienceOn
26 Fox PC. Salivary enhancement therapies. Caries Res 2004;38:241-246   DOI   PUBMED   ScienceOn
27 Glantz P, Friberg S. Time-dependent rheological behaviour of saliva. Odontol Revy 1970;21:279-285   PUBMED
28 Vissink A, Waterman HA, 's-Gravenmade EJ, Panders AK, Vermey A. Rheological properties of saliva substitutes containing mucin, carboxymethylcellulose or polyethylenoxide. J Oral Pathol 1984;13:22-28   DOI   PUBMED
29 Tenovuo J. Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis 2002;8:23-29   DOI   PUBMED   ScienceOn
30 Suh KI, Lee JY, Chung JW, Kim YK, Kho HS. Relationship between salivary flow rate and clinical symptoms and behaviors in patients with dry mouth. J Oral Rehabil 2007;34:739-744   DOI   ScienceOn
31 Park WK, Chung JW, Kim YK, Chung SC, Kho HS. Influences of animal mucins on lysozyme activity in solution and on hydroxyapatite surfaces. Arch Oral Biol 2006;51:861-869   DOI   ScienceOn
32 Valdez IH, Fox PC. Diagnosis and management of salivary dysfunction. Crit Rev Oral Biol Med 1993;4: 271-277   DOI
33 Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:28-46   DOI   ScienceOn
34 Scannapieco FA, Bergy EJ, Reddy MS, Levine MJ. Characterization of the salivary $\alpha$-amylase binding to Streptococcus sanguis. Infect Immun 1989;57: 2853-2863   PUBMED
35 Waterman HA, Blom C, Holterman HJ,'s-Gravenmade EJ, Mellena J. Rheological properties of human saliva. Arch Oral Biol 1988;33:589-596   DOI   ScienceOn
36 Mandel ID. The functions of saliva. J Dent Res 1987;66:436-441   DOI   PUBMED   ScienceOn
37 Blixt-Johansen G, Ek AC, Ganowiak W et al. Improvement of oral mucosa with mucin containing artificial saliva in geriatric patients. Arch Gerontol Geriatr 1992;14:193-201   DOI   ScienceOn
38 Ibrahim HR, Matsuzaki T, Aoki T. Genetic evidence that antibacterial activity of lysozyme is independent of its catalytic function. FEBS Letters 2001;506:27-32   DOI   ScienceOn
39 Levine MJ. Development of artificial salivas. Crit Rev Oral Biol Med 1993;4:279-286   DOI
40 Vissink A, De Jong HP, Busscher HJ, Arends J,'s-Gravenmade EJ. Wetting properties of human saliva and saliva substitutes. J Dent Res 1986;65: 1121-1124   DOI   PUBMED   ScienceOn
41 Mansson-Rahemtulla B, Baldone DC, Pruitt KM, Rahemtulla F. Specific assays for peroxidases in human saliva. Arch Oral Biol 1986;31:661-668   DOI   ScienceOn
42 Sreebny LM, Valdini A. Xerostomia part I: relationship to other oral symptoms and salivary gland performance. Oral Surg Oral Med Oral Pathol 1988;66:451-458   DOI   ScienceOn
43 Epstein JB, Emerton S, Le ND, Stevenson-Moore P. A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol 1999;35:132-137   DOI   ScienceOn
44 Grossowicz N, Ariel M. Methods for determination of lysozyme activity. Methods Biochem Anal 1983; 29:435-446   DOI   PUBMED